Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Edith Mitchell, MD, FACP
<< Back to Our Featured Experts
Dr. Edith Mitchell on Cancer Disparities Among African American Patients
Dr. Mitchell on Survival and Safety of the VELOUR Trial
Dr. Mitchell on Colorectal Cancer Treatment Options
Dr. Mitchell on a Subgroup Analysis of the VELOUR Trial
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Omar Nadeem, MD
Eric S. Nadler, MD
Sukumar Nagendran, MD
Jarushka Naidoo, MBBCh
Arpana M. Naik, MD
Kazuhiko Nakagawa, MD, PhD
Sujatha Nallapareddy, MD
Azadeh Namakydoust, MD, FACP
Dhanya K. Nambiar, PhD
Dhanya K. Nambiar
Dhanya K. Nambier, PhD
Rita Nanda, MD
Julie R. Nangia, MD
Julie R. Nangia
David Nanus, MD
David M. Nanus, MD
Amol K. Narang, MD
Elham Nasri, MD
Loretta J. Nastoupil, MD
Paul D. Nathan, MBBS, PhD, FRCP
Nitya Nathwani, MD
R. Wendel Naumann, MD
Shoba A. Navai, MD
Aziz Nazha, MD
Joel Neal, MD
Joel Neal, MD, PhD
Joel Neal, MD, PhD
Sattva Neelapu, MD
Sattva S. Neelapu, MD
Douglas A. Nelson, MD
Leigh A. Neumayer, MD
Thomas A. Neville, PhD
Lisa A. Newman, MD
Lisa Newman, MD, MPH, FACS, FASCO
Vincent Y. Ng, MD
Paul Nghiem, MD, PhD
Trung Nguyen, DO, MBA
Marie Huong Nguyen, MD
Torsten O. Nielsen, MD, PhD, FRCPC
Ruben Niesvizky, MD
Yuri E. Nikiforov, MD, PhD
Stephen D. Nimer, MD
Ajay K. Nooka, MD, MPH, FACP
Andrew Norden, MD, MPH, MBA
Luke Nordquist, MD
Luke Nordquist, MD, FACP
Silvia Novello, MD, PhD
Yelena Novik, MD
Grzegorz S. Nowakowski, MD
Brian Nussenbaum, MD
Lauren Nye, MD
OncLive News Network On Location: ASH 2019 Day 1
Trending Now
Osimertinib Now Standard in Frontline
EGFR+
NSCLC, But Potential for Progress Remains
Acalabrutinib Alone or in Combination Improves PFS in Frontline CLL
Acalabrutinib Triplet Highly Active in Frontline CLL
Dr. Ng on Immunotherapy in Micrometastatic High-Risk Soft Tissue Sarcoma
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe